Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

UNOMEDICAL A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 2.2% 2.2%   Bankruptcy risk   18.5% 2.3% 2.3% 2.3% 1.3% 0.5% 4.5% 4.2%   Credit score (0-100)   8 66 64 63 79 98 47 49   Credit rating   B BBB BBB BBB A AA BBB BBB   Credit limit (mDKK)   0.0 0.0 0.0 0.0 31.0 228.1 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1.0 Income statement (mDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   1,598 1,722 1,980 2,116 2,564 2,647 2,647 2,647   Gross profit   779 821 913 951 1,103 906 0.0 0.0   EBITDA   669 677 747 741 973 768 0.0 0.0   EBIT   669 677 747 741 881 702 0.0 0.0   Pre-tax profit (PTP)   562.4 520.4 587.4 596.5 2,548.1 751.2 0.0 0.0   Net earnings   562.4 520.4 587.4 596.5 2,403.9 534.6 0.0 0.0   Pre-tax profit without non-rec. items   669 677 747 741 2,548 751 0.0 0.0     See the entire income statement 1.0 Balance sheet (mDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 777 845 0.0 0.0   Shareholders equity total   1,558 2,082 2,671 2,673 2,205 1,832 1,004 1,004   Interest-bearing liabilities   0.0 0.0 0.0 0.0 130 336 0.0 0.0   Balance sheet total (assets)   0.0 2,931 3,532 3,429 2,735 2,622 1,004 1,004   Net Debt   0.0 0.0 0.0 0.0 123 328 -990 -990     See the entire balance sheet 1.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   1,598 1,722 1,980 2,116 2,564 2,647 2,647 2,647   Net sales growth   -8.3% 7.7% 15.0% 6.8% 21.2% 3.2% 0.0% 0.0%   Gross profit   779 821 913 951 1,103 906 0.0 0.0   Gross profit growth   -18.4% 5.4% 11.2% 4.1% 16.1% -17.9% -100.0% 0.0%   Employees   307 299 336 396 475 465 0 0   Employee growth %   7.3% -2.6% 12.4% 17.9% 19.9% -2.1% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   0 2,931 3,532 3,429 2,735 2,622 1,004 1,004   Balance sheet change%   -100.0% 0.0% 20.5% -2.9% -20.2% -4.1% -61.7% 0.0%   Added value   668.5 677.0 746.9 741.1 880.9 767.6 0.0 0.0   Added value %   41.8% 39.3% 37.7% 35.0% 34.4% 29.0% 0.0% 0.0%   Investments   -269 0 0 0 714 -10 -847 0   Net sales trend   -1.0 1.0 2.0 3.0 4.0 5.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   41.8% 39.3% 37.7% 35.0% 37.9% 29.0% 0.0% 0.0%   EBIT %   41.8% 39.3% 37.7% 35.0% 34.4% 26.5% 0.0% 0.0%   EBIT to gross profit (%)   85.8% 82.5% 81.8% 78.0% 79.8% 77.5% 0.0% 0.0%   Net Earnings %   35.2% 30.2% 29.7% 28.2% 93.8% 20.2% 0.0% 0.0%   Profit before depreciation and extraordinary items %   35.2% 30.2% 29.7% 28.2% 97.3% 22.7% 0.0% 0.0%   Pre tax profit less extraordinaries %   41.8% 39.3% 37.7% 35.0% 99.4% 28.4% 0.0% 0.0%   ROA %   47.0% 23.1% 23.1% 21.3% 87.7% 30.3% 0.0% 0.0%   ROI %   52.1% 23.1% 23.1% 21.3% 92.8% 35.1% 0.0% 0.0%   ROE %   38.3% 14.3% 24.7% 22.3% 98.6% 26.5% 0.0% 0.0%   1.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   100.0% 100.0% 100.0% 100.0% 80.6% 69.8% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 18.6% 27.6% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 18.3% 27.3% -37.4% -37.4%   Net int. bear. debt to EBITDA, %   0.0% 0.0% 0.0% 0.0% 12.6% 42.8% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 5.9% 18.3% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 231.9% 25.6% 0.0% 0.0%   1.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0   Current Ratio   0.0 0.0 0.0 0.0 2.0 1.0 0.0 0.0   Cash and cash equivalent   0.0 0.0 0.0 0.0 7.2 7.9 0.0 0.0   1.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 54.5 23.2 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 27.4 25.2 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 36.7% 26.3% 37.4% 37.4%   Net working capital   0.0 0.0 0.0 0.0 464.3 -35.3 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 18.1% -1.3% 0.0% 0.0%   1.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   5 6 6 5 5 6 0 0   Added value / employee   2 2 2 2 2 2 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   2 2 2 2 2 2 0 0   EBIT / employee   2 2 2 2 2 2 0 0   Net earnings / employee   2 2 2 2 5 1 0 0